Noninvasive biomarkers for liver inflammation in NAFLD: current and future.
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and molecular hepatology"
DOI: 10.3350/cmh.2022.0426
Abstract: Inflammation is the key driver of liver fibrosis progression in nonalcoholic fatty liver disease (NAFLD). Unfortunately, it is often challenging to assess inflammation in NAFLD due to its dynamic nature and poor correlation with liver… read more here.
Keywords: inflammation; biomarkers liver; nafld current; liver inflammation ... See more keywords
Screening for NAFLD—Current Knowledge and Challenges
Sign Up to like & getrecommendations! Published in 2023 at "Metabolites"
DOI: 10.3390/metabo13040536
Abstract: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of abnormal liver function tests worldwide, with an estimated prevalence ranging between 19–46% in the general population. Of note, NAFLD is also expected to become… read more here.
Keywords: current knowledge; knowledge challenges; disease; screening nafld ... See more keywords